CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors

Core Insights - CYIOS Corporation announced the resignation of David Lewis, who returned 16,560 Series D Preferred Shares and canceled all salary and loan obligations, strengthening the company's balance sheet and simplifying its capital structure [1] - The company is completing PCAOB-audited financial statements for the past two years, with 2024 fully completed, enhancing transparency and compliance [2] - CYIOS is focusing on increasing working capital through strategic investments to pay down Noir Medical Supplies' debt obligations, expected to be completed by mid-2026 [2] - The company is engaging AI and SaaS advisors to develop CyioIQ, an AI-driven medical platform aimed at improving operational efficiency and profitability [3] - CYIOS Corporation operates across multiple industries, including medical supplies, technology, and fintech, with a focus on sustainable profitability through its subsidiary Noir Medical Supplies [4]